Translate Bio (TBIO) Prices 9M Share Common Offering at $10/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
After-Hours Movers 9/17: (CDW) (KDMN) Higher; (FDX) (PTCT) (ADBE) Lower (more...)
September 17, 2019 5:43 PM EDTToday's After-Hours Movers
FedEx (NYSE: FDX) 9.3% LOWER; reported Q1 EPS of $3.05, $0.11 worse than the analyst estimate of $3.16. Revenue for the quarter came in at $17.05 billion versus the consensus estimate of $17.06 billion. FedEx sees FY2020 EPS of $11.00-$13.00, versus the consensus of $14.70.
PTC Therapeutics, Inc. (NASDAQ: PTCT) 7.7% LOWER; announced today that it is commencing a public offering of $100.0 million of shares of its common stock. PTC intends to grant the underwriter an option for a... More
Translate Bio (TBIO) Announces Proposed Common Share Offering
September 17, 2019 4:02 PM EDTTranslate Bio, Inc. (NASDAQ: TBIO) today announced that it has commenced an underwritten public offering of $90 million of its common stock. Translate Bio also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of... More
